Author:
Ljungblad Linda,Bergqvist Filip,Tümmler Conny,Madawala Samanthi,Olsen Thale Kristin,Andonova Teodora,Jakobsson Per-Johan,Johnsen John Inge,Pickova Jana,Strandvik Birgitta,Kogner Per,Gleissman Helena,Wickström Malin
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference86 articles.
1. Management of high-risk medulloblastoma;Bouffet;Neurochirurgie,2021
2. Current therapy for medulloblastoma;Gottardo;Curr. Treat. Options Neurol.,2006
3. Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the childhood cancer survivor study;King;Neuro-Oncology,2017
4. Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study;Sabel;J. Neuro-Oncol.,2016
5. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas;Kool;Acta Neuropathol.,2012
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献